|
51 |
Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
Enthalten in Annals of hematology Bd. 100, 31.7.2021, Nr. 11, date:11.2021: 2727-2732
|
|
|
|
52 |
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Enthalten in Bone marrow transplantation Bd. 59, 13.4.2024, Nr. 7, date:7.2024: 1012-1021
|
|
|
|
53 |
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
Enthalten in Annals of hematology Bd. 102, 10.7.2023, Nr. 9, date:9.2023: 2543-2553
|
|
|
|
54 |
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party
Enthalten in Bone marrow transplantation Bd. 59, 4.6.2024, Nr. 9, date:9.2024: 1239-1246
|
|
|
|
55 |
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Enthalten in Blood cancer journal Bd. 14, 15.3.2024, Nr. 1, date:12.2024: 1-8
|
|
|
|
56 |
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data
Enthalten in Bone marrow transplantation Bd. 60, 5.11.2024, Nr. 1, date:1.2025: 103-106
|
|
|
|
57 |
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Enthalten in Nature cancer Bd. 5, 13.5.2024, Nr. 8, date:8.2024: 1227-1249
|
|
|
|
58 |
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
Enthalten in Genome medicine Bd. 17, 30.6.2025, Nr. 1, date:12.2025: 1-14
|
|
|
|
59 |
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis
Enthalten in Annals of hematology Bd. 100, 3.9.2021, Nr. 11, date:11.2021: 2733-2744
|
|
|
|
60 |
Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial
Enthalten in Bone marrow transplantation Bd. 57, 18.8.2022, Nr. 11, date:11.2022: 1664-1670
|
|
Administration
